News

Filter

Current filters:

VaccinesPharmaceutical

1 to 9 of 516 results

Takeda consolidates business in Singapore, opening new office

Takeda consolidates business in Singapore, opening new office

25-02-2015

Japanese drug major Takeda has opened its new office in Biopolis, Singapore. The space will host its…

PharmaceuticalProductionResearchSingaporeTakeda PharmaceuticalsVaccines

Vaccines a $25.5 billion business in 2014; report

Vaccines a $25.5 billion business in 2014; report

13-02-2015

Vaccines are a big business, and a growing business, says health care market researcher Kalorama Information,…

GlaxoSmithKlineMarkets & MarketingMerck & CoNovartisPfizerPharmaceuticalSanofiVaccines

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

11-02-2015

UK pharma major GlaxoSmithKline this morning said that it has acquired Switzerland-based GlycoVaxyn,…

GlaxoSmithKlineGlycoVaxynMergers & AcquisitionsPharmaceuticalVaccines

CHMP issues positive opinion on new schedule for Sanofi Pasteur's Hexyon

CHMP issues positive opinion on new schedule for Sanofi Pasteur's Hexyon

09-02-2015

The European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on an…

EuropeHexyonPharmaceuticalRegulationSanofi PasteurSanofi Pasteur MSDVaccines

MSF hits out at Pfizer's 'tiny' price reduction on Prevenar 13 in developing countries

MSF hits out at Pfizer's 'tiny' price reduction on Prevenar 13 in developing countries

27-01-2015

US pharma giant Pfizer has announced commitments to reduce the price of Prevenar 13 (pneumococcal polysaccharide…

Medecins Sans FrontiersPfizerPharmaceuticalPrevenarPricingVaccines

Novartis’ meningitis B vaccine Bexsero approved by US FDA

Novartis’ meningitis B vaccine Bexsero approved by US FDA

24-01-2015

On Friday, the US Food and Drug Administration granted accelerated approval of Swiss pharma giant Novartis’…

BexseroNovartisPharmaceuticalRegulationUSAVaccines

Milestone for GSK/NIH candidate Ebola vaccine as first doses shipped for Phase III trial

Milestone for GSK/NIH candidate Ebola vaccine as first doses shipped for Phase III trial

23-01-2015

UK pharma major GlaxoSmithKline said this morning that the first batch of its candidate Ebola vaccine…

EbolaGlaxoSmithKlinePharmaceuticalResearchUKVaccines

Success of India-developed meningitis A vaccine MenAfriVac

Success of India-developed meningitis A vaccine MenAfriVac

20-01-2015

Meningitis A, that threatens the lives of 450 million people across 26 countries in Africa's ‘Meningitis…

HealthcareIndiaMenAfriVacPharmaceuticalSerum Institute of IndiaSub-Saharan AfricaVaccines

1 to 9 of 516 results

COMPANY SPOTLIGHT

Menarini

Back to top